NCT06992102View on ClinicalTrials.gov

Clinical Study on the Treatment of Lower Respiratory Tract Infection With Pseudomonas Aeruginosa by Ceftazidime and Avibatam

CompletedOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions

MDRPA

Trial Locations (1)

21000

The First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT06992102 - Clinical Study on the Treatment of Lower Respiratory Tract Infection With Pseudomonas Aeruginosa by Ceftazidime and Avibatam | Biotech Hunter | Biotech Hunter